I wasn't trying to put words in your mouth. As to the dangers of "pinkies", well, lets just say I posted about that most recently about CBIS and for many years as a whole. Millionaire, now that's funny. Bashing, I have never bashed a stock, and if that's what you are getting out of my pointing to facts, well then you can just get back up on your soap box if you choose.
Safe investments, well, yes, there are many. However, we aren't talking about those are we? As to the products that CBIS is working on, that's as unclear as having a facility to not having one, or acquiring a brand or not. I say this because if one reads their filings they clearly state they're not about legalizing Marijuanna.
Referring to your statement-The product CBIS are working with is not recognized by the feds as a legal product.
Recent Developments
Cannabis Science is laying a solid foundation for entrance into the FDA and other government regulatory agencies for developing medicines for cancer, autism, Influenza, PTSD and other ailments.
The Company's goal is not the legalization of marijuana, but instead the development of FDA-approved and legal non-smoked cannabis-based medicines.
Furthermore, what I am pointing out is that they are inconsistant other than the fact that they don't finish one thing before starting another or repeat a similar goal that has been mentioned previously in a PR, with the pattern consistant to whatever may be the hot topic in the media at the moment.
That said, they say things are moving fast and then in their filngs state-
We are currently not in good short-term financial standing. We anticipate that we may only generate any limited revenues in the near future and we will not have enough positive internal operating cash flow until we can generate substantial revenues, which may take the next two years to fully realize. There is no assurance we will achieve profitable operations. We have historically financed our operations primarily by cash flows generated from the sale of our equity securities and through cash infusions from officers and outside investors in exchange for debt and/or common stock.
Yet, state in a PR they expect to make over $6 million in 2012.
Lastly, so we ae clear as to what I have been pointing out is they're actions are misleading at best. Yes, yes, it's pinkyville.
That's still not an excuse nor does it dismiss the "fact" that they have cause a great deal of confusion and misleading their shareholders by saying one thing and printing another in their filings. Which I will not go into filings any further as it is clear they are not very good at filing them.
BTW-you are you trying to put words in my?
You stated- You did your DD I assume and liked what you saw. Now the stock is tanking and you blame the company. Everyone wants to become a millionaire over night here, but when stock tanks the bashing begins.
Yes, I did my DD, though not as well as I should have. I should have looked into the pattern of their PR's along with other red flags. Yes, I playing the MOMO, but do believe that the science can be a benefit. but come on, they have shot themselves in the foot several time in the last 60 days. The cannabis movement and what CBIS has claimed are in many ways two different issues.
I believe I've said enough in the past few days.
Clearly the ball is in their court...
AI
Market Data 
Markets 
